Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma

Clinical trial NCT05263583 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05263583
Sponsor: Cothera Bioscience, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High-grade B-cell Lymphoma Burkitt Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse Lymphatic Diseases Lymphoma, High-Grade C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma C-Myc Gene Rearrangement

Start date: 2022-12-09
Primary completion: 2025-03-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.